AstraZeneca to seek approval for blood pressure drug by year-end
By Pushkala Aripaka (Reuters) -AstraZeneca plans to file for regulatory approval of its experimental blood pressure treatment before the end of the year, a senior company executive said, about a product seen as key to the drugmaker’s long-term sales strategy. The company is aiming for potential approvals in 2026 for the drug, baxdrostat, starting with …
AstraZeneca to seek approval for blood pressure drug by year-end Read More »










